跳至主要内容
临床试验/IRCT201311199858N5
IRCT201311199858N5已完成未知

Effect of Risperidone on reducing the symptoms of methamphetamine induced psychosis

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • 1. At least 18 years of age
  • 2. Diagnosis of methamphetamine induced psychosis with structured clinical interview SCID by the approval of a psychiatrist or a psychologist.
  • 3. No anti-psychotic drug use.
  • 4. No other psychological disorders.
  • Exclusion criteria:
  • Patient's unwillingness to continue to participate in the study.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验